Telemedicine Flexibilities for Prescription of Controlled Medications Extended Through End of 2024

The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced an extension of current telemedicine flexibilities for controlled substances through Dec. 31, 2024.

This second extension will allow patients and practitioners time to adapt to the final set of telemedicine regulations that the DEA and HHS are expected to release in fall 2024. To view the full article, click here.